Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn’s Disease with no Relapse After Switching to Adalimumab

被引：6
|
作者：
Marilia Cravo
Rosa Silva
Miguel Serrano
机构：
[1] Instituto Português de Oncologia de Lisboa Francisco Gentil,Gastroenterology Department
[2] Hospital Central do Funchal,Gastroenterology Department
[3] Instituto Português de Oncologia Francisco Gentil,Serviço de Gastrenterologia
来源：
BioDrugs | 2010年 / 24卷
关键词：
Infliximab; Etanercept; Adalimumab; Budesonide; Psoriatic Arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Infliximab and adalimumab are anti-tumor necrosis factor (TNF) alpha agents used for treating Crohn’s disease. Autoimmune hepatitis (AIH) is a rare complication of treatment with these drugs. We report on a case of AIH in a patient with Crohn’s disease treated with infliximab who fully recovered after drug withdrawal. More interestingly, because there were no other treatment options, the patient was then treated with adalimumab without recurrence of the liver disease and with control of the intestinal disease.
引用
收藏
页码：25 / 27
页数：2
相关论文
共 50 条
  • [1] Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn's Disease with no Relapse After Switching to Adalimumab
    Cravo, Marilia
    Silva, Rosa
    Serrano, Miguel
    [J]. BIODRUGS, 2010, 24 : 25 - 27
  • [2] Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease
    Miranda-Bautista, Jose
    Menchen, Luis
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (05): : 306 - 307
  • [3] Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case
    Dahlia A. Goldfeld
    Elizabeth C. Verna
    Jay Lefkowitch
    Arun Swaminath
    [J]. Digestive Diseases and Sciences, 2011, 56 : 3386 - 3388
  • [4] Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn's disease: The Index Case
    Goldfeld, Dahlia A.
    Verna, Elizabeth C.
    Lefkowitch, Jay
    Swaminath, Arun
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (11) : 3386 - 3388
  • [5] Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease
    Avila Alvarez, A.
    Garcia-Alonso, L.
    Solar Boga, A.
    Garcia-Silva, J.
    [J]. ANALES DE PEDIATRIA, 2009, 70 (03): : 278 - 281
  • [6] Infliximab Drug-Induced Autoimmune Hepatitis in Patient With Crohn's Ileocolitis
    Karanfilian, Briette
    Mahpour, Noah
    Reja, Debashis
    Sarkar, Avik
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1360 - S1360
  • [7] Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis
    Karanfilian, Briette
    Mahpour, Noah
    Sarkar, Avik
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (06) : E741 - E743
  • [8] Mesalazine induced autoimmune hepatitis in a patient with Crohn's disease
    ter Avest, Milou M.
    van Hee, Koen
    Bronkhorst, Carolien
    de Jonge, Hendrik J. M.
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [9] Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept
    K. M. Carlsen
    L. Riis
    O. R. Madsen
    [J]. Clinical Rheumatology, 2009, 28 : 1001 - 1003
  • [10] Elective Switching from Infliximab to Adalimumab in Stable Crohn's Disease
    Hoentjen, Frank
    Haarhuis, Bertram J. T.
    Drenth, Joost P. H.
    de Jong, Dirk J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 761 - 766
12345